bevacizumab

Dr. Reddy’s Laboratories announces the launch of Versavo® (bevacizumab biosimilar) in India

Hyderabad, August 22, 2019: Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY) announced today that it has launched…

5 years ago

Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis

New Delhi, May 18, 2018: Patients in Cuba will have better access to therapy for lymphoma and rheumatoid arthritis The…

6 years ago